Confluence Investment Management’s Natus Medical Inc NTUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-167,040
| Closed | -$5.47M | – | 322 |
|
|
2022
Q2 | $5.47M | Sell |
167,040
-30,130
| -15% | -$952K | 0.09% | 135 |
|
|
2022
Q1 | $5.18M | Buy |
197,170
+12,570
| +7% | +$307K | 0.07% | 150 |
|
|
2021
Q4 | $4.38M | Buy |
184,600
+3,837
| +2% | +$94.7K | 0.06% | 161 |
|
|
2021
Q3 | $4.53M | Buy |
180,763
+1,230
| +0.7% | +$31.3K | 0.06% | 159 |
|
|
2021
Q2 | $4.67M | Buy |
179,533
+4,256
| +2% | +$116K | 0.06% | 158 |
|
|
2021
Q1 | $4.49M | Buy |
175,277
+21,998
| +14% | +$564K | 0.06% | 154 |
|
|
2020
Q4 | $3.07M | Buy |
153,279
+2,669
| +2% | +$52.3K | 0.05% | 175 |
|
|
2020
Q3 | $2.58M | Sell |
150,610
-1,909
| -1% | -$36.1K | 0.04% | 169 |
|
|
2020
Q2 | $3.33M | Sell |
152,519
-2,560
| -2% | -$58.6K | 0.06% | 158 |
|
|
2020
Q1 | $3.59M | Sell |
155,079
-3,367
| -2% | -$97.9K | 0.07% | 151 |
|
|
2019
Q4 | $4.07M | Buy |
158,446
+1,539
| +1% | +$49.3K | 0.07% | 161 |
|
|
2019
Q3 | $5M | Sell |
156,907
-1,539
| -1% | -$44.9K | 0.08% | 150 |
|
|
2019
Q2 | $4.07M | Sell |
158,446
-166,837
| -51% | -$4.25M | 0.07% | 161 |
|
|
2019
Q1 | $8.26M | Sell |
325,283
-475,295
| -59% | -$14.2M | 0.14% | 115 |
|
|
2018
Q4 | $27.2M | Sell |
800,578
-71,424
| -8% | -$2.32M | 0.51% | 55 |
|
|
2018
Q3 | $31.1M | Sell |
872,002
-88,672
| -9% | -$3.13M | 0.53% | 56 |
|
|
2018
Q2 | $33.1M | Sell |
960,674
-32,677
| -3% | -$1.15M | 0.58% | 52 |
|
|
2018
Q1 | $33.4M | Sell |
993,351
-28,741
| -3% | -$910K | 0.62% | 51 |
|
|
2017
Q4 | $39M | Sell |
1,022,092
-22,069
| -2% | -$881K | 0.71% | 49 |
|
|
2017
Q3 | $39.2M | Buy |
1,044,161
+585,088
| +127% | +$20.6M | 0.75% | 46 |
|
|
2017
Q2 | $17.1M | Buy |
459,073
+362,326
| +375% | +$13.1M | 0.35% | 63 |
|
|
2017
Q1 | $3.8M | Buy |
96,747
+16,583
| +21% | +$622K | 0.08% | 138 |
|
|
2016
Q4 | $2.79M | Buy |
80,164
+8,355
| +12% | +$328K | 0.07% | 155 |
|
|
2016
Q3 | $2.82M | Buy |
71,809
+2,134
| +3% | +$85.1K | 0.07% | 154 |
|
|
2016
Q2 | $2.63M | Buy |
69,675
+42,928
| +160% | +$1.44M | 0.07% | 157 |
|
|
2016
Q1 | $1.03M | Buy |
+26,747
| New | +$996K | 0.03% | 189 |
|
Other funds holding NTUS
Confluence Investment Management's NTUS Position: Q3 2022 in Review
Confluence Investment Management sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 167,040 shares — an estimated $5.47M sold.
Confluence Investment Management first reported a position in NTUS in Q1 2016 and held it in 26 quarters. The position peaked at $39.2M in Q3 2017. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.
- Confluence Investment Management reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
- Confluence Investment Management sold 167,040 Natus Medical Inc shares in Q3 2022, an estimated $5.47M.
- Confluence Investment Management first reported a position in Natus Medical Inc in Q1 2016 and held it in 26 quarters.
- Confluence Investment Management's Natus Medical Inc position peaked at $39.2M in Q3 2017.
- 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.
Based on Confluence Investment Management's 13F filing for Q3 2022, filed 3 Oct 2022.